| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Xenon Pharmaceuticals Inc. (XENE) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 28 sells. XENE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 225.0K | $12.84M | - | |
| Other | 40.0K | $2.28M | - | |
| CEO | 19.9K | $1.14M | - | |
| Dir | 17.0K | $970.8K | - | |
| Dir | 17.0K | $970.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 5, 2025 | Gannon Steven | Director | Sell | 3 | $30.48 | $91.44 | - | +26.4% | - | |
| Jan 27, 2025 | Mortimer Ian53 | President &CEO | Sale+OE | 55,000 | $40.25 | $2,213,996.75 | -30.5% | -5.7% | +5.7% | |
| Dec 18, 2024 | Aulin Sherry | Chief Financial Officer | Sale+OE | 18,709 | $41.21 | $770,911.67 | -100% | -10.6% | +9.9% | |
| Nov 22, 2024 | Patou Gary50 | Director | Sale+OE | 4,891 | $41.08 | $200,946.61 | -9.4% | -4.3% | +0.0% | |
| Mar 8, 2024 | Garofalo Elizabeth A.50 | Director | Sale+OE | 2,092 | $45.69 | $95,583.48 | -100% | -18.2% | -21.1% | |
| Mar 7, 2024 | Robin Sherrington50 | EVP, Strategy &Innovation | Sale+OE | 7,137 | $46.28 | $330,290.25 | -23.7% | -17.3% | -20.9% | |
| Mar 7, 2024 | Gannon Steven | Director | Sell | 13,000 | $46.28 | $601,614.90 | -31.0% | -17.3% | -20.9% | |
| Dec 13, 2023 | Patou Gary50 | Director | Sale+OE | 18,978 | $39.99 | $758,982.88 | -20.1% | +10.9% | -1.1% | |
| Aug 24, 2023 | Svoronos Dawn | Director | Sell | 25,000 | $38.70 | $967,500.00 | -50.0% | -25.0% | +6.4% | |
| Jun 1, 2023 | Pimstone Simon N.60 | Director | Sale+OE | 131,245 | $38.90 | $5,104,970.28 | -60.7% | +0.6% | -1.5% |